Specific meetings can focus on any of the following aspects of the management of antiretroviral therapy (ART):
- Selecting First-line ART
- Ask an Expert: Answers to Your HIV Questions
- ART Strategies in Advanced Clinical Development for 2018
- Evolving Approaches to ART Modification
- Current Controversies in HIV
- How Common Comorbidities Affect ART Management
- How Aging Affects ART Management
- Plus updates on new HIV data from the major scientific meetings of the year, including CROI, IAC, and IDWeek
The timing and agenda for each individual meeting is as follows:
- Welcome, CME information, and baseline outcomes questions (10 mins)
- Case 1 discussion followed by didactic slides (10-15 mins)
- Case 2 discussion followed by didactic slides (10-15 mins)
- Case 3 discussion followed by didactic slides (10-15 mins)
- Question and answer session, concluding outcomes questions (15-20 mins)
Princy N. Kumar, MD, FIDSA, MACP
Professor of Medicine and Microbiology
Chief, Division of Infectious Diseases and Travel Medicine
Senior Associate Dean of Students
Georgetown University School of Medicine
Geeta Gupta, MD
UCI Medical Center
Director, AIDS Education and Training Center
University of California, Irvine
The goal of this activity is to improve participants’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary antiretroviral regimens.
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals who provide care for HIV-infected patients.
- Apply best practices when selecting first-line antiretroviral regimens for HIV-infected patients
- Integrate treatment modification strategies when appropriate for patients already receiving antiretroviral therapy
- Provide individualized care for key populations of HIV-infected patients, according to factors such as age, comorbid conditions, and concomitant medications
- Provide insightful counsel to patients and colleagues regarding antiretroviral strategies in development
- Pharmacists will be able to provide appropriate counsel to patients and other members of the treatment team
- Nurses will be able to provide appropriate counsel for patients and their families
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine, the Annenberg Center and Clinical Care Options. The Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Albert Einstein College of Medicine designates this live meeting for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is designated for up to 1.0 contact hours (0.1 CEUs) of continuing pharmacy education credit. Individual topic ACPE UANs available within the Event Date tab.
Type of Activity: Knowledge
For Pharmacists: Upon receipt of the completed activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.
Nursing Continuing Education
Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 contact hour may be earned for successful completion of this activity.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13664, for 1.0 contact hour.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be emailed to you within 4 weeks.
Disclosure of Conflicts of Interest
The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relationship with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
The Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine have no conflict of interest with commercial interests related directly or indirectly to this educational activity.
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Peer Reviewer: Barry S. Zingman, MD, Medical Director, AIDS Center; Clinical Director, Infectious Diseases, Moses Division; and Professor of Clinical Medicine at Albert Einstein College of Medicine has no real or apparent conflicts of interest to report.